Volume 11, Number 6—June 2005
Research
Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States
Matthew J. Kuehnert*, Holly A. Hill*, Benjamin A. Kupronis*, Jerome I. Tokars*, Steven L. Solomon*, and Daniel B. Jernigan*
Table 1
Staphylococcus aureus–related discharge diagnoses, United States, 1999–2000, by patient age and infection site*
| Discharge diagnosis | Age (y) |
||||
|---|---|---|---|---|---|
| <14 | 15–44 | 45–64 | >65 | Total† | |
| S. aureus septicemias | 2,918 | 12,272 | 20,028 | 38,948 | 74,166 |
| Proportion of methicillin-resistant isolates from blood culture | 0.144 | 0.317 | 0.392 | 0.495 | 0.424 |
| MRSA septicemias | 420 | 3,890 | 7,851 | 19,279 | 31,440 |
| S. aureus pneumonias | 2,328 | 5,582 | 6,926 | 41,427 | 56,263 |
| Proportion of methicillin-resistant isolates from lower respiratory culture | 0.195 | 0.333 | 0.467 | 0.586 | 0.530 |
| MRSA pneumonias | 454 | 1,859 | 3,234 | 24,276 | 29,823 |
| Other S. aureus infections | 14,290 | 39,222 | 40,496 | 67,105 | 161,113 |
| Proportion of methicillin-resistant isolates from other culture sites | 0.160 | 0.279 | 0.378 | 0.539 | 0.402 |
| Other MRSA infections | 2,286 | 10,943 | 15,307 | 36,170 | 64,706 |
*MRSA, methicillin-resistant S. aureus.
†Due to rounding of methicillin-resistant proportions, total MRSA infections may differ slightly when estimates are calculated across category groups by row (i.e., age) compared with column (i.e., infection site).
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.